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Although colorectal cancer screening has proven to reduce mortality rates from colorectal cancer, 
there still remains to be a relatively low percent of people participating in preventative measures 
specific to colorectal cancer. National data shows that less than half of adults aged 50 years or 
older have ever been screened for colorectal cancer, only 26% had a fecal occult blood test in the 
past two years and 53% ever having a sigmoidoscopy or colonoscopy (National Center for 
Chronic Disease Prevention and Health, 2004). In Wisconsin, approximately 27% of similarly 
aged adults report having a fecal occult blood test; 59% a sigmoidoscopy or colonoscopy 
(National Center for Chronic Disease Prevention and Health, 2004). Even though numbers in 
Wisconsin are higher than the national average, the numbers are still lower than the desired 75% 
(American Cancer Society Challenge Goals, Principles, & Nationwide Objectives, 1996). 
An obvious major determinant in frequency of colorectal screening is access to health 
care. One subpopulation for which access to health care is often an issue includes those living in 
rural areas. Specifically, rural areas have the potential for decreased access to screening due to 
physical proximity limitations, lack of specialists in the area, and appropriate health insurance. 
The purpose of this study was twofold: first to examine if any differences exist between 
rural and urban providers' colorectal cancer screening practices and attitudes; second, to identify 
factors that account for such differences. Findings from this study suggest that there are 
significant differences between rural and urban providers' colorectal cancer screening practices. 
Interestingly, the differences were not found in the overall frequency rate of screening (6 1 % 
rural; 68% urban), but in the method of screening. Rural providers had a statistically significant 
higher rate of screening with FOBT and urban providers with colonoscopy, even though both 
rural and urban providers perceived their patients to prefer a colonoscopy over FOBT screening. 
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CHAPTER ONE 
Introduction 
Strong evidence supports that the number of individuals dying of colorectal cancer could 
be greatly reduced through appropriate screening. The American Cancer Society set a nationwide 
goal to increase the proportion of people aged 50 years or older who have colorectal cancer 
screening, consistent with the American Cancer Society guidelines, to 75% by the year 20 15 
(American Cancer Society Challenge Goals, Principles, & Nationwide Objectives, 1996). Ideally, 
the most comprehensive and preferred screening method to be used is a colonoscopy, which is 
referred to as the "gold standard" for screening colorectal cancer. 
Even though there is general agreement that adults aged 50 years or older should be 
screened for colorectal cancer, national survey data shows less than half of these adults have ever 
been screened for this cancer. The 2004 Behavioral Risk Factor Surveillance System surveyed 
U.S. citizens who were 50 years or older (National Center for Chronic Disease Prevention and 
Health, 2004). This study found that in 2004,26% of respondents reported having a fecal occult 
blood test within the past two years and 53% reported ever having had a sigmoidoscopy or 
colonoscopy. Specifically, data for Wisconsin is slightly higher than the national average, yet still 
fall far from the ideal (National Center for Chronic Disease Prevention and Health, 2004)). 
About 27% of Wisconsinites over 50 reported having a fecal occult blood test and 59% reported 
ever having a sigmoidoscopy or colonoscopy. 
Health care providers greatly influence patient's decisions in regard to having a colorectal 
cancer screening procedure. Research has shown that physician recommendation for colorectal 
cancer screening is one of the strongest predictors of patient screening utilization (Vernon, 1997; 
Mandelblatt & Kanetsy, 1995; Taplin, Urban, Taylor & Savarino, 1997; Brenes & Paskett, 2000). 
Cibula and Morrow (2003) found that the main source of information patients had regarding 
colon cancer screening were medical providers, specifically physicians and nurses; less 
informative were television, magazine and news articles. In addition, patients who had been 
advised to have a fecal occult blood test were nearly four times as likely to have ever had this test 
compared to patients who were not advised to do so (Cibula &Morrow, 2003). An additional 
issue of concern is that although a national survey found that primary care physicians perceived 
colonoscopy to be the most effective method of screening for colorectal cancer, 80% of the 
physicians most often recommend non-colonoscopy screening, specifically fecal occult blood 
testing andlor flexible sigmoidoscopy (Klabunde, Frame, Meadow, Jones, Nadel & Vernon, 
2003). 
In 1999, members of the Medical College of Wisconsin surveyed 600 primary care 
physicians in Wisconsin to document current physician attitudes and practices regarding 
colorectal cancer screening (Taylor & Anderson, 2002). There were large differences found 
between the estimated percent of screening rates for the different methods. Only 3% of 
physicians estimated that 50% or more of their patients are screened with colonoscopy, while 
62% estimated that over half of their patients are screened with fecal occult blood testing. Further 
results suggest that there is an inconsistency of physician belief and practice. Although 98% of 
respondents either strongly or slightly agreed to the statement, "Every patient over 50 years of 
age should be screened for colorectal cancer," only 28% respondents estimated that they screened 
75% or more of their patients who are 50 years or older. To explain this inconsistency, two 
different explanations have been generated. 
The first pertains to the fact that the 1999 research study did not examine how many 
physicians recommend patients 50 years or older to have a screening procedure. There may be a 
discrepancy between physician's belief and practice due to behaviors and attitudes of his or her 
patients, not necessarily of the physician. A physician may think every patient who is 50 and 
older should be screened, and recommend this to every patient who fits the criteria, but still have 
a low screening rate of patients who are actually screened due to factors related to the patient and 
area of residence. 
A second possible explanation of the inconsistency in provider belief and practice is that 
unfortunately the 1999 study did not differentiate between providers who practice in a rural or 
urban area. Rural providers may have been overrepresented, which may account for low 
screening rates of certain colorectal cancer screening methods such as a colonoscopy. Rural areas 
have a smaller percentage of doctors and a higher percentage of healthcare providers such as 
physician assistants and nurse practitioners due to the affordability of their services and the 
difficulty in recruiting and retaining physicians (Rosenblatt & Hart, 2000). Roughly, 20% of the 
U.S. population reside in a rural area, but only 9% of the nation's physicians practice in these 
areas (Bureau of Rural Health Profession, 1992), however 30 % of physician assistants practice 
in rural areas (Medline Plus, 2005). These types of providers can't perform a colonoscopy, but 
can only recommend the procedure to be done, thus making the reported percentage of 
performing the actual procedure of a colonoscopy look smaller simply because the providers 
surveyed can't perform the procedure. Other reasons that may have accounted for low colorectal 
cancer screening rates, if indeed rural providers were over-represented in the study, is the 
difference in rural patients' remote location and distant access to appropriate healthcare facilities. 
Older adults living in isolated areas may not have physical access to a facility that offers the 
procedure or may not have comprehensive insurance, or any insurance at all, to cover the 
expense. Another possible reason could be that patients in rural areas don't have an 
understanding of the importance of having a colonoscopy versus a fecal occult blood test or may 
be intimidated by its invasive procedure. 
Statement of the Problem 
Although colorectal cancer screening has proven to reduce mortality rates from colorectal 
cancer, there still remains to be a relatively low percent of age appropriate people participating in 
preventative measures specific to colorectal cancer. This has been identified nationally as well as 
in the state of Wisconsin. Not only are the low numbers for screening colorectal cancer alarming, 
the healthcare discrepancies in rural areas have potential for even lower screening numbers. 
Purpose of the Study 
This research is an exploratory study set forth to assess colorectal cancer screening 
practices and attitudes of family practice and internal medicine providers, located throughout six 
west-central Wisconsin counties. Of particular interest is identifying any differences among the 
urban and rural providers. Lastly, this study will identify and explore factors that account for any 
provider reported differences in screening for colorectal cancer. 
Hypotheses 
Although this study was predominately exploratory, specific hypotheses were tested. The 
first set hypothesized that there would be a relationship between providers' estimated percent of 
recommending a colorectal cancer screening procedure with the providers' estimated percent of 
actual screening for colorectal cancer. 
Hal: There will be no relationship between the provider's estimated rate of 
recommending a colorectal cancer screening procedure to patient's 2 50 years of 
age with the provider's estimated rate of patients 2 50 who have actually been 
screened. 
HI: There will be a relationship between the provider's estimated rate of 
recommending a colorectal cancer screening procedure to patients 2 50 years of 
age with the provider's estimated rate of patients 2 50 who have actually been 
screened. 
The second set concerned hypothesized differences in practices between rural and urban 
providers. 
HO2: There will be no percentage difference for screening for colorectal cancer in 
patients 2 50 between urban and rural sites. 
H2: The urban sites will have a greater percentage of screening for colorectal 
cancer in patients 2 50 than rural sites. 
HO3: There will be no percentage difference for screening for colorectal cancer 
with colonoscopies in patients 2 50 between urban and rural sites. 
H3: Urban sites will have a greater percentage of screening for colorectal cancer 
with colonoscopies in patients 2 50 than rural sites. 
The third set hypothesized that provider's attitudes and beliefs regarding colorectal cancer 
screening would predict engagement of certain screening methods. Specifically: 
HO4: Provider's attitude regarding the effectiveness of a colorectal cancer 
screening procedure's ability to reduce mortality from colorectal cancer will not 
predict engagement in that screening procedure. 
H4: Provider's attitudes regarding the effectiveness of a colorectal cancer 
screening procedure's ability to reduce mortality from colorectal cancer will 
predict engagement in that screening procedure. 
H4*: There will be a relationship between a provider's belief that 
screening for colorectal cancer with fecal occult blood testing 
reduces mortality from colorectal cancer with the provider's 
estimated percentage of screening patients by fecal occult blood 
testing. 
&B: There will be a relationship between a provider's belief that 
screening for colorectal cancer with flexible sigmoidoscopy 
mortality from colorectal cancer with the provider's estimated 
percentage of screening patients by flexible sigmoidoscopy. 
H4C: There will be a relationship between a provider's belief that 
screening for colorectal cancer with colonoscopy reduces mortality 
from colorectal cancer with the provider's estimated percentage of 
screening patients by colonoscopy. 
Lastly, it was hypothesized that the provider's level of familiarity of the screening guidelines 
would be related to their overall screening rate, regardless of type of method. 
HO5: There will be no relationship between providers who are familiar with the 
American Cancer Society screening guidelines and their general colorectal cancer 
screening practices. 
H5: There will be a relationship between level of familiarity with the American 
Cancer Society guidelines and general colorectal cancer screening practices. 
Assumptions of the Study 
The participants of this study were family practice and internal medicine providers. The 
subject selection was based on the assumption that these providers would be the providers most 
likely to screen patients for colorectal cancer. Family practice providers are the largest source of 
physicians in rural communities as well as being evenly distributed in proportion to the 
population for both urban and rural areas (Bureau of Health Professions, 1997). 
The categorization of rural and urban was largely based on the rural-urban continuum 
code. However, one site that was located in an urban county was classified as a rural location due 
to the size and distance from the closest non-rural city. The assumption was made that this 
location had more rural characteristics. By doing this, the sub- sample sizes of urban and rural 
providers were more evenly distributed. 
Definition of Terms 
Colorectal cancer. Cancer of the colon, rectum, appendix and anus. 
Incidence. The number of cancers that develop in a population during a defined 
period of time. 
Morbidity. The number of cases of a certain disease that exist at some given point in time. 
Mortality. The number of deaths due to a particular cause. For example the number of 
deaths caused by colorectal cancer. 
Prevalence. The number of cancers that exist in a defined population at any given point in 
time. 
Rural. The definition of "rural" is based on the rural - urban continuum code determined 
by the Office of Management and Budget (OMB). This continuum consists of nine codes 
and is used to classify all U.S. counties by degree of urbanization and proximity to a 
metropolitan area. Table 1 illustrates the nine rural - urban continuum codes. 
Table 1 
Rural - Urban Continuum Code 
Code Definition 
Metropolitan 
0 Central counties of metropolitan areas of 1 million population or more 
1 Fringe counties of metropolitan areas of 1 million population or more 
2 Counties in metropolitan areas of 250,000 to 1 million population 
3 Counties in metropolitan areas of fewer than 250,000 population non-metropolitan counties 
Non-metropolitan 
4 Urban population of 20,000 or more, adjacent to a metropolitan area 
5 Urban population of 20,000 or more, not adjacent to a metropolitan area 
6 Urban population of 2,500 to 19,999, adjacent to a metropolitan area 
7 Urban population of 2,500 to 19,999, not adjacent to a metropolitan area 
8 Completely rural or fewer than 2,500 urban population, adjacent to a metropolitan area 
9 Completely rural or fewer than 2,500 urban population, not adiacent to a metropolitan area 
Sensitivity. The ability of a test to correctly detect individuals within a population 
who have a certain disease. 
SpeciJicity. The ability of a test to correctly detect individuals within a population 
who do not have a certain disease. 
Limitations of the Study 
This study only assessed family practice and internal medicine providers who practice 
within a certain healthcare system. Findings cannot be generalized outside of this specific 
healthcare system. 
Methodology 
The remaining paper is divided into chapters. Chapter two goes into detail of the 
development of cancer, both predisposing and lifestyle risk factors and the importance of 
prevention. The different screening methods approved by the American Cancer are discussed 
along with rural healthcare factors and issues of access to healthcare. 
Chapter three describes the methodology and the subjects of this study. Explanation of 
the instrument is broken down by provider's screening preferences, screening behaviors, 
influential factors affecting screening behaviors, attitude and knowledge of colorectal cancer and 
provider demography. The procedure used for data collection, detail of data analyses for the 
hypotheses and limitations of the study conclude chapter three. 
Chapter four presents the results for provider demographics, along with significant 
differences found between rural and urban provider demographics, and analysis of the proposed 
hypotheses. 
Chapter five summarizes the first three chapters and discusses the results of the study. 
CHAPTER TWO: LITERATURE REVIEW 
General 
Cancer is the second leading cause of all deaths after heart disease. In 2001, cancer was 
the culprit for 23% of all deaths in the United States, claiming 553,768 lives (US Mortality 
Public Use Data Tape, 2001; National Center for Health Statistics, Centers for Disease Control 
and Prevention, 2003). Whereas many rates of disease have decreased since 1950 such as heart 
disease, the death rate per 100,000 people from cancer remains relatively unchanged. Lung 
cancer is the number one cancer killer, affecting both men and women. The second killer for 
women is breast cancer and for men is prostate cancer. The third cancer killer in the United 
States for both men and women is colorectal cancer. It is estimated that there will be 150,484 
new cases and 56,370 deaths from colorectal cancer in 2004 (American Cancer Society, 2004a) 
even though colorectal cancer is curable if detected early. 
Development of Cancer 
Cancer begins when the genetic material within a normal cell, known as DNA, suffers 
some type of permanent change or mutation. The genetic changes in the DNA are responsible for 
initiating the actions that can lead to cancer. The body's cells have a natural balance of cell 
growth and death, as new cells continually reproduce, older cells die out. Normal cells replicate 
at a steady rate and have innate "stop" signals that instruct the cells to stop dividing. Cancerous 
cells have lost this balance and never die out. They replicate at a much faster pace and have lost 
the signals that tell the cells to stop producing and continue to multiply. When this happens, the 
accumulation of cells in one location occurs and a tumor forms (President and Fellows of 
Harvard College, 2001). 
In the colon and rectum area, this abnormal cell growth can lead to a polyp or raised 
clump of cells. While 90% of polyps are not cancerous, nearly all colon cancers start as polyps. 
Colorectal cancer is thought to develop from a changing and developing polyp over the course of 
at least five years. The two most common types of polyps are hyperplastic and adenomas. 
Hyperplastic polyps are generally less than 5 millimeters in size and contain an abnormal amount 
of normal-looking cells, but tend not to be cancerous (President and Fellows of Harvard College, 
2001). Some of these cells in the polyp become abnormal through mutations, changing the polyp 
into a lesion called an adenoma. Adenomas tend to become cancerous by loss of a tumor 
suppressor gene as they grow, especially if they surpass 5 millimeters in size (Willis, Fuda & 
Chenault, 2002; Repertoire, 2002; Mayo Clinic Staff, 2003; President and Fellows of Harvard 
College, 2001). The etiology of cancerous polyps is considered sporadic, with some familial 
predisposition and lifestyle factors (Willis, et al, 2002). 
Risk Factors 
Predisposing Risk Factors 
Predisposing risk factors account for only 25% of all new cases of colorectal cancer 
(Sargent & Murphy, 2003). For most people, the biggest risk factor for developing colorectal 
cancer is their age. Over 90% of people who are diagnosed with colorectal cancer are over 50 
years of age (American Cancer Society, 2004a; President and Fellows of Harvard College, 2001). 
The incidence of colorectal cancer increases as people age. For example, at age 50, fewer than 1 
in 1,000 people are afflicted with colorectal cancer. However, at age 85 the incidence rises to 7 in 
1,000 (President and Fellows of Harvard College, 2001). This corresponds with the fact that the 
cellular changes in the colon or rectum takes many years to develop to a cancerous form. 
Adenomas, the precancerous polyps, become more common with age. At age 50, approximately 
one third of all Americans have adenomas. At age 70, nearly one half of all Americans will have 
them (President and Fellows of Harvard College, 2001). 
Inherited gene mutations are illnesses that can be passed down from one generation to the 
next. Two hereditary conditions known to cause 5% of colorectal cancers are familial 
adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) 
(President and Fellow of Harvard College, 2001). Familial adenomatous polyposis (FAP) is a 
rare condition that causes hundreds of polyps to grow in the rectum and colon (Repertoire, 2002; 
President and Fellow of Harvard College, 2001). This inherited illness affects close to 1 in 9,000 
people and accounts for approximately 1 % of colorectal cancers. Hereditary nonpolyposis 
colorectal cancer (HNPCC) causes approximately 2-4% of all colorectal caners. Unlike FAP, 
HNPCC does not cause large numbers of polyps to grow in the colorectal area. Instead the 
mutation is found in several genes that code for proteins that are responsible for mending errors 
in DNA. Therefore, these mutations interfere with the repair process in the DNA of the cell. This 
interference is thought to allow errors to grow in other key genes that control cell growth. The 
gene errors lead to the early onset of colorectal cancer, usually in the proximal colon, around the 
age of 46 (President and Fellow of Harvard College, 2001). 
A unique subpopulation has been identified as having a higher risk for developing 
colorectal cancer than the general population. Approximately 6% of Jews with ancestors from 
Eastern Europe, known as Ashkenazi Jews, are at higher risk. They have inherited a flaw in the 
gene that suppresses tumor growth, the APC gene. The general population has a 5% risk for 
colorectal cancer; however, this defect puts Ashkenazi Jews at an 8-30% risk (President and 
Fellow of Harvard College, 2001). 
A family history of colorectal cancer increases a person's risk of developing this type of 
cancer. Mainly, having a first-degree relative, either a parent or sibling, who developed colorectal 
cancer before age 60 increases the risk of developing colorectal cancer. About 15% of people 
who have colorectal cancer have a strong family history. In addition, having first-degree relatives 
who have developed polyps before age 60, or two or more first-degree relatives who developed 
polyps at any age, places a person at higher-than-average risk (President and Fellow of Harvard 
College, 200 1) 
There are certain medical conditions that increase a person's risk of developing colorectal 
cancer. Ulcerative colitis, which is a bowel disease that causes inflammation or ulceration of the 
intestines, causes the greatest risk. People who have been afflicted by this disease for a long 
period of time have a risk for colorectal cancer that is 20-fold or more above the general 
population (President and Fellow of Harvard College, 200 1) 
Lifestyle Factors 
The risk factors stated above (age, heredity, family and personal history) are mainly out of 
a person's control. However, there are other variables associated with an increased risk for 
colorectal cancer that have been identified, and these variables a person can control. Referred to 
as lifestyle factors, they are discussed below. 
Energy imbalance has been identified as a critical factor in development of colorectal 
cancer (Giovannucci, 2003). Consuming excessive amounts of calories in relation to the amount 
of calories needed to maintain a normal body weight has consistently shown to increase risk of 
colorectal cancer. Since it is difficult to accurately calculate energy balance, measures of body 
mass index have been used to estimate long-term energy balance. Studies have found that a 
higher body mass index is linked with increased colorectal cancer (Wu, Paganini-Hill, Ross & 
Henderson, 1987; Giovannucci, Asherio, Rimm, Colditz, Stampfer & Willet, 1995; Le 
Marchand, Wilkins & Mi, 1992). Having a body mass index greater than 25 increases the risk for 
developing colorectal cancer (President and Fellow of Harvard College, 2001). Many overweight 
people are also sedentary. Numerous studies have shown that individuals who are physically 
active are at a lower risk for colorectal cancer (Colditz, Cannuscio & Frazier, 1997). Colon 
cancer incidence is reduced approximately 30-50% among people with the highest level of 
physical activity compared to those with low levels of activity (Giovannucci, 2003). 
Research suggests that high consumption of alcohol increases the risk of colorectal cancer 
(Kune &Vitetta, 1992). An interaction effect seems to play a larger role than just alcohol alone. 
Higher risks have consistently been observed among individuals with high consumption of 
alcohol and low intakes of folate (Freudehheim, Graham, Marshall, Haughey, Cholewinski & 
Wilkinson, 199 1 ; Baron, Sandler, Haile, Mandel, Mott & Greenberg, 1992). A report indicated 
that women who are at higher risk for colorectal cancer because of family history could reduce 
their risk if they either had high intakes of folate or took a multivitamin (Fuchs, Willett, Colditz, 
Hunter, Stampfer, Speizer, & Giovannucci, 2002). The relation between alcohol and folate may 
be related to alcohol's antagonist effect on folate metabolism (Hillman & Steinberg, 1982). 
Research is finding a link between colorectal cancer and dietary fat and cholesterol 
(President and Fellows of Harvard College, 2001). The risk of developing colorectal cancer 
increases as the level of total saturated fat and cholesterol increase. The food most associated 
with colorectal cancer is red meat. Not only is red meat high in saturated fat, but also under high 
temperatures, such as broiling or grilling, meat under goes a chemical change, which creates 
cancer-causing carcinogens. During digestion, the carcinogens come into contact with the bowel 
wall, which may produce colorectal cancer. 
Prevention 
Even though colorectal cancer has a high incidence, it is one of the most detectable 
cancers. Fortunately, if colorectal cancer is detected early, and still localized in the rectal area, 90 
percent of patients survive five or more years (Sargent & Murphy, 2003). Unlike many other 
types of cancer, colorectal cancer is easy to identify during screening tests. Regular screening to 
identify and remove polyps is critical because most colorectal cancers begin as polyps. Yet, only 
1% of polyps become cancerous, and there is no a priori way of identifying which polyp is 
cancerous. Thus, early detection and removal of all polyps by routine screening is vital. Doing so 
reduces the chance of ever acquiring this disease by 75%. 
It's important to participate in regular screening rather than waiting for symptoms to be 
expressed because early signs can be as vague, nonspecific symptoms such as weight lose, 
fatigue or weakness. Other symptoms that indicate advanced growth of colorectal cancer could 
be a change in bowel habits, diarrhea, constipation or a sensation that the bowel does not empty 
completely, bright red or dark blood in the stool, unusually narrower stool, abdominal discomfort 
or vomiting. However, due to the fact that colorectal cancer develops slowly over a period of 
several years, the symptoms are often times not apparent until after the disease has progressed 
making chances of survival low (Mayo Clinic Staff, 2003). Waiting to be screened until 
symptoms are present may be too late. As such, prevention and early detection have a much 
greater potential to lower morbidity and mortality for colorectal cancer than treatments such as 
chemotherapy, radiation or surgery. 
Primary prevention is actively participating in a behavior that has been identified to 
decrease the risk of developing a specific disease. Getting regular exercise, reducing red meat 
consumption, not smoking nor drinking heavily, and regular screening are examples of primary 
prevention for colorectal cancer. Since the majority of colorectal cancers develop from polyps, 
regular screening to identify and remove polyps is considered vital prevention. 
General Information: Disease Screening 
According to Champion, Raw1 and Menon (2002), several conditions must be met before 
preventative screening makes sense in asymptomatic populations. Healthcare professionals must 
have a way to alter the disease course. The disease must have natural histories and biologies that 
can be predicted. In addition, preclinical phases must have high prevalence and incidence. In 
other words, the disease must affect a high percentage of the population to warrant screening 
practices. However, there must be effective treatment for early stage diseases after they are 
discovered for screening to be recommended. 
If the disease meets the necessary conditions for population screening, the screening tests 
must be specific and sensitive. Sensitivity refers to the ability to correctly identify people within 
a population who have the disease. All things being equal, it is commonly believed that the 
higher the sensitivity, the better the test. A test is not considered sensitive if it detects cancer only 
10% of the time. Specificity refers to the ability to correctly identify people within a population 
who do not have the disease. Specificity relates to patient anxiety and unneeded medical 
procedures. For example, if a test detects a positive result 50% of the time for people who do not 
have the disease, further unnecessary tests are done along with unnecessary anxiety of thinking 
they are ill. Tests must be able to find cancer if it is truly present while simultaneously correctly 
and confidently identifying its absence. 
An alternative way to conceptualize the appropriateness of a screening test is in terms of 
false positives and false negatives. False positives are abnormal results in people who are free 
from the disease, which can lead to unnecessary anxiety, costly medical expenses, and even 
invasive medical procedures. False negatives are normal results in people who actually have the 
disease. 
Lastly, experts must agree that the screening tests accurately detect the desired disease 
before organizations recommend population screening. Primarily, scientists look for tests that 
demonstrate significantly lower mortality from the targeted disease due to screening compared to 
a population who is not being screened (Champion, Raw1 & Menon, 2002). 
Colorectal Screening 
The goal of screening for colorectal cancer is to identify cancers and polyps in the colon 
and rectum. Table 2 illustrates the 2004 American Cancer Society colorectal cancer screening 
guidelines for average risk men and women (American Cancer Society, 2004b). 
Table 2 
American Cancer Society Colorectal Cancer Screening Guidelines 
Risk Category Test Options and Frequency 
Asymptomatic men and women age 50 and Fecal occult blood test (FOBT) annually. If 
older positive, follow up with colonoscopy 
Flexible sigmoidoscopy every 5 years 
Combination of FOBT annually and 
flexible sigmoidoscopy every 5 years 
a Double-contrast barium enema every 5 
years. If positive, follow up with 
colonoscopy 
Colonoscopy every 10 years 
Fecal Occult Blood Test 
Fecal occult blood test (FOBT) is used to chemically check stool for hidden blood 
(occult). The detection of occult blood in the stool may indicate cancer or polyps in the colon or 
rectum since approximately two-thirds of cancers bleed and some polyps bleed (Mayo Clinic 
Staff, 2003). It is a relatively convenient, noninvasive procedure that poses little risks and is 
inexpensive. 
FOBT is not a sensitive test and can miss early stages of cancers and polyps. Controlled 
studies involving large samples have shown that FOBT leads to a reduction in mortality rate from 
anywhere between 15-33% (Mandel, Bond, Church, Snover, Bradley, Schman & Ederer, 1993; 
Hardcastle, Chamberlain, Robinson, Moss, Arnar, Balfour, James & Mangham, 1996; Kronborg, 
Fenger, Olsen, Jorgensen & Sondergaard, 1996) and about a 20% decrease in cancer incidence 
(Mandel, Church, Bond, Ederer, Geisser, Mongin, Snover & Schuman, 2000). However, the 
sensitivity is low for detecting precancerous polyps, especially small ones (Bond, 2000; 1998; 
Borum, 2001). Due to the test's low sensitivity, there are still a large percentage (67-85%) of 
people dying from colorectal cancer who have used FOBT as a method of screening. Further, if 
blood is detected, the source of the bleeding is not known. False positives appear if blood is 
detected from other parts of the body that are bleeding. False negatives occur because not all 
cancers or polyps bleed, or bleed very little, leading patients to think they are fine when in fact 
they have a polyp or cancer. 
Flexible Sigmoidoscopy 
The bowel is divided into two sections called the distal and proximal bowel. The distal 
bowel accounts for the first third of the bowel containing the rectum, recto sigmoid junction and 
sigmoid colon. The remaining two-thirds of the bowel is called the proximal bowel, which 
includes the descending colon, splenic flexure, transverse colon, hepatic flexure, ascending 
colon, cecum and appendix. 
Flexible sigmoidoscopy allows for direct visualization of the distal bowel, along with the 
ability to obtain a biopsy specimen of suspicious lesions. This method rarely requires sedation 
and is less invasive and expensive compared to a colonoscopy. Nearly all cancers and polyps 
larger than one centimeter in diameter can be seen in the distal bowel with this technique. Some 
studies have shown that flexible sigmoidoscopy alone can reduce deaths from distal cancers by 
60-80%. (Bond, 2000; Borurn, 2001; Selby, Friedman, Quesenbeny & Weiss, 1992). However, 
lesions in the proximal bowel, or two-thirds of the bowel, are not detected. The percent of 
colorectal cancers in the proximal bowel that go undetected by flexible sigmoidoscopy have been 
reported to be as high 40% (Mayo Clinic Staff, 2003). 
Double Contrast Barium Enema 
Double contrast barium enema is used to detect changes or abnormalities in the colon. 
Barium and air are inserted into the colon through the rectum to aid in the view of the colon via 
an x-ray machine. This technique can detect 50-80% of polyps less than one centimeter in 
diameter and 70-90% of polyps one centimeter or larger. A one-time screening can detect around 
68-78% of advanced adenomas (Lieberman, Weiss, Bond, Ahnen, Garewal & Cheifec, 2000; 
Imperiale, Wagner, Lin, Larkin, Rogge & Ransohoff, 2000). 
Colonoscopy 
A colonoscopy is considered the "gold standard" for colorectal cancer detection. A 
colonoscopy allows visualization of the entire colon and rectum along with the option of 
removing biopsies of any abnormalities found. Although sedation and preparation are needed, it 
is the most sensitive test. Research has found that the use of colonoscopy reduced colorectal 
cancer incidence by 40-60% (Muller & Sonnenberg, 1995). One study found a single-test 
sensitivity to be 75% for small adenomas, 90% for large adenomas and higher than 90% for 
cancer (Rex, Cutler, Lemmel, Rahrnani, Clark, Helper, Lehrnan & Mark, 1997). 
If the individual has Medicare, all techniques are covered as of July 1, 2001 (Medicare 
Report, 2003), with the option to more frequent testing if at higher risk (Mayo Clinic Staff, 
2003). Unfortunately, the cost for a colonoscopy is the most expensive out of the other 
techniques and some insurance companies do not reimburse for the procedure. The relative cost 
of a colonoscopy is about $650 every 10 years (Rex, Johnson, Lieberman, Burt, & Sonnenburg, 
2000). Other tests are less expensive but done more frequently and are less accurate. 
Rural Issues 
General 
The characteristics that make a rural community unique such as isolation, small size and 
culture are factors that can also affect the health status of the residents. Not only is health status 
affected by demography and economy, but it is also affected by factors such as geographic 
isolation, culture of rural living, and the prolonged time it takes for more advanced technology 
and effective medical care to enter into the smaller communities (Hogan, 1986; Charlton, 1996; 
Park, Brook, Kosecoff, Keesey, Rubenstein, Keeler, Kahn, Rogers, Chassin, 1990). Even the 
composition of medical practice differs between rural and urban providers. Family practice 
providers are the largest source of physicians in rural communities (Bureau of Health 
Professions, 1997), whereas urban areas have more specialists. In comparison to non-rural areas, 
rural areas have different patient demographics, health risks and needs, lifestyles, access to 
healthcare, health insurance provider availability, resources, economies and effects of public 
policy. All of these factors lead to different health status and practices between rural and urban 
providers (Blumenthal & Kagen 2002; Mueller 2002; Moscovice & Stensland 2002; Drain, 
Godkin & Valentine 200 1). 
Rural Health 
Health and healthcare is closely related to the demography and economy of the 
community (Evan, Barer & Marmor, 1994). Table 3 illustrates that nationally; rural communities 
are generally poorer, have higher unemployment rates and are less educated than residents of 
urban communities. They also tend to have higher numbers of uninsured residents. In relation to 
urban elders, rural elders are less educated, have lower incomes, are more likely to be poor and 
are more likely to be in poorer health (Coward, McLaughlin, & Duncan, 1994). Lower economic 
status has been associated with lifestyle risk factors such as alcohol consumption and dietary 
factors (Broder, 1991). In addition, people with lower incomes and less education are more likely 
to report unrnet health needs, less likely to have health insurance coverage and less likely to 
receive preventative health care (Blumenthal & Kagen, 2002). 
Table 3 
Characteristics of Rural and Urban Populations in the United States 
Rural Urban 
Population density, persons per square mile (1 993) 18 202 
Median income of households (1 995) $27,776 $36,079 
Non-Hispanic, white $29,392 $40,342 
Black $16,530 $23,348 
Hispanic $21,322 $23,348 
Two-parent family $37,075 $5 1,023 
Female-headed family $17,182 $22,478 
Percent of families below poverty (1 995) 15.6% 13.4% 
Education of those older than 25 yrs (1 995) 
High school graduation 76.9% 82.9% 
Some college 37.8% 50.3% 
B.A. and higher 14.8% 25.0% 
Percent Foreign-Born 2.0% 1 1 .O% 
Rickett 111, Johnson-Webb & Randolph, Populations and Places in Rural America from Rural 
Health in the United States, Ricketts (ed) 1999. 
Access to Healthcare 
Many people are limited to physician care due to difficulty in accessing appropriate 
healthcare facilities and having adequate, if any health insurance. Rural residents often have to 
travel longer distances to receive healthcare (Edelman & Menz, 1996; Cunningham & Cornelius, 
1995). For the rural elderly, this creates bigger obstacles since only 12% of rural communities of 
populations less than 2,500 provide public transportation (Seccombe, 1995; Bridwell & 
Calesaric, 1996). Rural individuals under 65 years of age are less insured compared to those 
living in urban areas (Hartley, Quam, & Lurie, 1994). In addition, studies have found that urban 
families pay a lower proportion of their income for insurance premiums and have more insurance 
coverage than rural families (Mueller, Patil and Ullrich, 1997; Hartley, Quam, & Lurie, 1994). 
Medicare is important for rural Americans not only because a higher proportion of the rural 
population is elderly, but also because rural providers rely more heavily on the Medicare program 
than on other payers. This is partly due because rural residents are less likely to have 
employment-related insurance as many residents are self-employed (Frenzen, 1993). However, 
the Medicare program pays less per rural beneficiary compared to their urban counterparts and 
pay less for the same service provided in rural than in urban places (Mueller, Schoenman, & 
Dorosh, 1999). This lower reimbursement may be an incentive for providers to use the least 
expensive procedure for patients who are on Medicare even if they know another procedure is 
more comprehensive andlor to not provide any services to Medicare recipients. 
The 2002 Behavioral Risk Surveillance System data for colorectal cancer screening for 
Wisconsin residents shows the screening rates for FOBT and flexible sigmoidoscopy/ 
colonoscopy by income and education. Table 4 shows the lowest rate of ever having a flexible 
sigmoidoscopy or colonoscopy for individuals making less than $1 5,000; the highest rate for 
those earning between $25,000 - $34,999. 
Table 4 
Comparison of the Percentage of Wisconsin Residents Who have had a Colorectal Cancer 
Screening Procedure by Income Level 
Flexible Sigmoidoscopy/ 
Method FOBT Colonoscopy 
Income P N P N 
Less than $15,000 45.6 78 46.4 84 
$15,000-$24,999 44.8 175 53.7 205 
$25,000-$34,999 47.9 173 58.3 203 
$35,000-$49,999 54.2 120 52.9 129 
$50.000 + 46.3 191 57.1 228 
Table 5 shows a higher percentage of college graduates have had either a flexible sigmoidoscopy 
or colonoscopy compared to individuals who have had less education. 
Table 5 
Comparison of the Percentage of Wisconsin Residents Who have had a Colorectal Cancer 
Screening Procedure by Education Level 
Flexible Sigmoidoscopy/ 
FOBT Method Colonoscopy 
Education P N P N 
Less than H.S. 5 1.9 107 52.0 118 
H.S. or G.E.D. 44.8 334 54.3 402 
Some post H.S. 49.6 206 57.1 226 
College Graduate 52.9 242 61.2 28 1 
Summary 
In summary, differences in survival of malignant neoplasms have been observed between 
rural and urban populations (Homer & Chirkikos, 1987). Survival from disease is mostly 
dependent on early screening. Early screening and detection are related to availability of 
screening programs and access to health care facilities, which has shown to not be the same for 
urban and rural communities (Aday, 1 985; Battista & Spitzer, 1 983). 
In the study to be presented in the following chapters, two urban locations and multiple 
rural settings were sampled. Compared with the rural locations, the urban centers had the 
advantage of advanced technology, public transportation and closeness to oncologists and 
colonoscopies. 
The data gathered in this research study was funded by an American Cancer Society grant 
awarded to a healthcare system in west-central Wisconsin. The purpose of the grant was to 
increase family practice and internal medicine providers' knowledge of colonoscopy and to 
establish baseline data on attitudes and practices of colorectal cancer screening. To accomplish 
this, all family practice and internal medicine providers were sent the pre-test survey along with 
packets provided by the American Cancer Society, and then given a post-test to determine 
effectiveness of the packets. The results presented address the pre-test findings. Specifically, 
findings regarding differences in colorectal cancer screening attitudes and practices between 
urban and rural providers. 
CHAPTER THREE: METHODOLOGY 
Purpose 
This exploratory study examined colorectal cancer screening practices, attitudes and 
knowledge among family practice and internal medicine providers practicing in rural and urban 
areas of west central Wisconsin. Specific attention was given to the rural - urban comparison of 
screening rates for colorectal cancer, for which beneficial effects of screening have been 
demonstrated. 
Subjects 
The population of interest in this research was family practice and internal medicine 
providers within a west central Wisconsin healthcare system. This system offers a full range of 
medical services through a network of local areas including Eau Claire, Barron, Bloomer, 
Chetek, Chippewa Falls, Colfax, Mondovi, Osseo and Prairie Farm. Since the population size is 
small, not only were physicians included, but also physician assistants and nurse practitioners to 
increase the population size to 64 eligible providers. The full population (N = 64) was sent a 
survey, as each member of the population of interest was invited to participate in the study. 
Method 
The method used for attaining the data was a survey (Appendix A). This survey was a 
slight modification of the 2002 Wisconsin Colorectal Cancer Survey, which was designed by the 
Colorectal Cancer Task Force of the Wisconsin Chapter of the American Cancer Society to 
determine provider's knowledge of colorectal cancer screening and examine if there were 
differences between provider's beliefs and practices. This survey was modified to determine if 
there were differences between rural and urban providers, thus including location of the 
provider's practice. This survey also asked providers to estimate the percentage they 
recommended a colorectal screening procedure. 
Procedure 
On March 1, 2004 an informed consent letter addressed from an oncologist was sent to all 
family care and internal medicine providers in the healthcare system along with a 40-question 
survey. The surveys were sent out via interoffice mail and took approximately 15 to 20 minutes 
to complete. After one week, a follow-up survey was sent to all providers. Data analysis plans are 
described below. 
Measure 
The 40-item survey measured screening preferences, screening behaviors, influential 
factors affecting screening behavior and attitude and knowledge of colorectal cancer. The full 
survey is attached in appendix A. 
Screening Preference 
The first section of the survey asked providers to mark their preferred screening methods, 
what they perceived as their patient's preferred methods and provider's preferred method of 
screening for self. The options the providers had to choose from were the following: fecal occult 
blood testing every year (FOBT), flexible sigmoidoscopy every 5 years, FOBT every year 
combined with flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, double 
contrast barium enema every 10 years or other. 
Screening Behaviors 
The providers were asked to estimate the percentage of patients over the age of 50 for 
whom they recommended a colorectal cancer screening procedure; the percentage actually 
screened; and the percentage screened with the following: fecal occult blood testing, flexible 
sigmoidoscopy and colonoscopy. 
Influential Factors of Screening for Colorectal Cancer 
Providers were asked if they used a paper or computer reminder system for when patients 
are due for colorectal cancer screening. In addition, there was a question that asked which factors 
would make them more likely to screen for colorectal cancer. They were also asked if their 
screening practices have changed within the past four years. Additional questions were asked to 
help determine reasons as to why their screening practices changed and what influenced their 
screening practices. 
Attitude and Knowledge of Colorectal Cancer 
A rating scale was used to assess their level of agreement with statements about 
familiarity and knowledge of the American Cancer Society guidelines, perceived patient 
compliance of the three screening methods, factors that affect colonoscopy screening and beliefs 
of which screening method they thought reduced mortality from colorectal cancer. 
Provider Demography 
In order to describe the population from which the data was gathered, eight demographic1 
descriptive questions were asked. They included whether or not the provider currently performed 
flexible sigmoidoscopy or colonoscopy, gender, age range, type of medical license, year received 
medical degree, department of practice and location of practice. 
Data Analysis 
Planned 
The Statistical Program for Social Sciences, version 13.0, (SPSS, 2004) was used to 
analyze the data. A number of statistical analyses were used in this study. All of the questions on 
the survey were analyzed as a whole sample and also analyzed separately by rural and urban 
location. An alpha level of .05 was used for all statistical tests. 
Hypothesis I. 
The Pearson r correlation analysis was used to determine if a relationship exist between 
the percentage of patients who are recommended for a colorectal cancer procedure and the 
percentage of patients who are actually screened. 
Hypotheses 2 & 3. 
Independent Groups T-Test analyses were conducted to assess differences between rural 
and urban sites in their overall estimated screening practice rates and estimated colonoscopy 
rates. 
Hypothesis 4. 
The Pearson r correlation analysis was used to explore if there was a relationship between 
provider's beliefs and practices. This was done by correlating the percentage of patients who 
were actually screened by fecal occult blood testing with the belief that screening with fecal 
occult blood testing reduces mortality from colorectal cancer; the percentage of patients who 
were screened by flexible sigmoidoscopy and the belief that screening with flexible 
sigmoidoscopy reduces mortality from colorectal cancer and the percentage of patients who were 
screened for colorectal cancer by colonoscopy with the belief that screening for colorectal cancer 
by colonoscopy reduces mortality from colorectal cancer. 
Hypothesis 5. 
The Pearson r correlation analysis was used to explore if there was a relationship between 
providers who were familiar with the American Cancer Society screening guidelines and their 
general colorectal cancer screening practices. This was done by correlating provider's level of 
agreement to their familiarity with the guidelines, with their self-reported estimation of screening 
patients for colorectal cancer in general, regardless of the screening method. 
Post-HOC 
Given the exploratory nature of this study, post-hoc analyses will be performed. The post- 
hoc questions will be based upon the findings from the planned five hypotheses and will employ 
the appropriate statistical method. An alpha level of .05 was used for all statistical tests. 
Limitations 
A limitation of the instrument was discovered when the surveys were returned. Question 
number 5 asked, "Estimate what percentage of your patients over 50 years of age who are 
actually screened for colorectal cancer," and question number 6 asked, "Estimate what 
percentage of your patients over 50 years of age who are actually screened for colorectal cancer 
with: fecal occult blood testing %, flexible sigmoidoscopy-%, colonoscopy~%'7 Most 
providers have a percent for number 5 (i.e. 85% who actually were screened) and then 100% of 
that number (85%) was broken into the 3 options (i.e. 30% FOBT, 10% flexible sigmoidoscopy 
and 60% colonoscopy). This would have been interpreted as of the 85% of the people who were 
screened, 30% were screened with FOBT, 10% were screened with flexible sigmoidoscopy and 
60% were screened with colonoscopy. However, there were some providers who gave a percent 
for question number 5 (i.e. 55% were actually screened) and then answered question number 6 
with 50% were screened with FOBT and 5% were screened with colonoscopy. In order for this to 
be interpreted like the first example, the percentages for question number 6 was recalculated, for 
example, 50% of 55% is actually 90.1% for FOBT and 5% of 55% is 9.09% for colonoscopy. 
This way it could be interpreted that of the 55% of people who were screened, 90% were 
screened with FOBT and 9% were screened with colonoscopy. Responses that were clearly 
adding up the individual method responses to the number of their estimated overall screening 
percentage, and not 100% of the overall screening percentage, were recalculated to give a true 
percentage. This amount of interpretation on the overall percentage of screening by FOBT and 
colonoscopy does put some limitations on the conclusions found due to manipulating the 
estimated percentage of each method, however it was quite apparent what the respondent's 
intentions were, making this researcher confident in the recalculations. 
Some providers overlapped their percentages for the 3 methods in question number 6 
(i.e., 30% for FOBT, 30% flexible sigmoidoscopy and 70% for colonoscopy). When this was 
done, the answer was not changed due to the fact that FOBT and flexible sigmoidoscopy are 
combined as a screening technique. Thus, this study was not able to distinguish if providers were 
using FOBT alone or in conjunction with flexible sigmoidoscopy. 
The sample size of this study does present statistical weakness. Since the size of the 
sample is small, there may be significant differences that go unnoticed. However, it also reflects 
the reality of the number of providers available. 
CHAPTER FOUR 
RESULTS 
The purpose of this study was to explore provider's colorectal cancer screening practices 
from a west central Wisconsin healthcare system. A 23-item survey was distributed in the spring 
of 2004 to all family practice and internal medicine providers, including physician assistants and 
nurse practitioners. 
Demographics 
Response Rate 
There were a total of 5 1 respondents out of a possible 64 for a response rate of 80%. 
However, the "n" size for the 5 hypotheses differs due to respondents not answering every 
question on the survey. 
Location 
The locations were the name of the town or city in which the provider practiced. Due to 
the small sample size of the location, analysis of results per location was not possible. Thus, the 
locations were then categorized into either "rural" or "urban" based on the rural-urban continuum 
codes (Rural Policy Context - web). The rural category consisted of 24 providers and the urban 
category consisted of 26 providers. To see which locations were categorized rural or urban, refer 
to Appendix B. 
Gender 
About 61% (n = 3 1) of the sample were males and 39% (n = 20) were females. The ratio 
of males to females within the rural and urban categories reflected the overall gender distribution 
of providers. Of the providers who practiced in a rural location, 63% (n = 15) were males and 
38% (n = 9) were females. Likewise, of the providers who practiced in an urban location, 62% (n 
= 16) were males and 38% (n = 10) were females. 
Age 
Approximately 73% (n = 38) of the providers were between the ages of 30-49. Table 6 
shows the most frequent age group for rural providers (41.6%, n = 10) were in the group 30-39 
and the age group 40-49 was the second most frequent (29.2%, n = 7). The reverse is true for 
urban providers. The most frequent age group for urban providers (42.3%, n = 11) was the group 
40-49 and the second most frequent (30.7%, n = 8) was the group aged 30-39. 
Table 6 
Distribution of Rural and Urban Providers' Age 
Age Range 
Under 3 0 30-39 40-49 50-59 60-69 Over 70 Total 
Urban 1 3.8 8 30.7 11 42.3 4 15.4 2 7.7 0 0.0 26 52 
Total 1 2.0 18 36.0 18 36.0 9 18.0 3 6.0 1 2.0 50 100 
Type of Licensure 
The majority (80.4%, n = 41) of providers had medical degrees. Of the urban providers, 
100% (n = 26) had medical degrees. Of the rural providers, 58.3% (n = 14) had medical degrees, 
25% (n = 6) were physician assistants, 12.5% (n = 3) were nurse practitioners and 4.2% (n = 1) 
was a doctor of osteopathic medicine. 
Department of Practice 
Overall, 78% (n = 39) of the providers worked in family practice. Of urban providers, 
62% (n = 16) were in family practice and 39% (n = 10) were in internal medicine. Of the rural 
providers, approximately 96% (n = 23) were in family practice and 4% (n = 1) were in internal 
medicine. 
Year Received Medical Degree 
The mean year for which providers received their medical degree was 1987 (N = 49, SD 
= 10.3, minimum = 1958, maximum = 2003). Rural providers' mean year of reception of medical 
degree was 1988 (n = 24, SD = 10.6, minimum = 1960, maximum = 2002). Urban providers' 
mean year of reception of medical degree was 1985 (n = 25, SD = 10.1, minimum = 1958, 
maximum = 2003). 
Signzficant demographic differences found between rural and urban providers. 
Pearson chi-square was used to determine if there were any demographic differences 
between rural and urban providers. Two significant differences were found; the first concerned 
was type of medical licensure (k2 = 13.54, p < .05). All urban providers had a medical degree (n 
= 26) compared to only 58% (n = 14) of rural providers. The second significant pertained to 
medical department (k2 = 8.55, p < .05). Almost all rural providers (96%) work in family 
practice, whereas 62% (n = 16) of urban doctors work in family practice and 39% (n = 10) work 
in internal medicine. What this means is that almost fifty percent of rural providers do not have a 
medical license and of those who do, their area of expertise is in family medicine, not in a 
specialty area such as internal medicine. 
Hypotheses 
Hypothesis One 
The first hypothesis stated there would be a relationship between providers' estimated 
percent of recommending a colorectal cancer screening procedure with the actual estimated 
percent of screening for colorectal cancer. 
Hal: There will be no relationship between the provider's estimated rate of 
recommending a colorectal cancer screening procedure to patient's 2 50 years of 
age with the provider's estimated rate of patients 2 50 who have actually been 
screened. 
HI: There will be a relationship between the provider's estimated rate of 
recommending a colorectal cancer screening procedure to patients 3 50 years of 
age with the provider's estimated rate of patients 2 50 who have actually been 
screened. 
The null hypothesisl was rejected. The Pearson r moment coefficient test indicated a 
positive relationship between provider's estimated percent of patients that were recommended for 
screening with the provider's estimated percent of patients who were actually screened (r = .504, 
p < .05). Since cause and effect cannot be determined by a test of correlation, this could have two 
meanings. One interpretation is that the more the providers recommend patients to be screened 
for colorectal cancer, the more the providers screen patients for colorectal cancer. This suggests 
that if providers increase the rate to which they recommend their patients to be screened for 
colorectal cancer, the rate to which the patients are actually screened should increase as well. 
Another interpretation could be that the more the providers screen their patients, the more the 
providers will recommend a screening test. 
This illustrates the importance of providers recommending patients to be screened and the 
effects on patients providers' habitual screening.. If providers do not recommend patients to be 
screened, there is less of a chance that the patients will be screened. Also, if providers are not in 
the habit of screening, they are less likely to recommend a screening procedure. 
Hypotheses T w o  and Three 
The second and third hypotheses pertained to differences in screening practices between 
rural and urban providers. 
HO2: There will be no percentage difference for screening for colorectal cancer in 
patients 2 50 between urban and rural sites. 
H2: The urban sites will have a greater percentage of screening for colorectal 
cancer in patients 3 50 than rural sites. 
HO3: There will be no percentage difference for screening for colorectal cancer 
with colonoscopies in patients 2 50 between urban and rural sites. 
H3. Urban sites will have a greater percentage of screening for colorectal cancer 
with colonoscopies in patients 2 50 than rural sites. 
Table 7 shows the estimated mean percentage for rural and urban providers' screening 
practices. Null hypothesis2 failed to be rejected. Independent samples t-tests were analyzed to 
determine differences between rural and urban provider's estimated screening rates for colorectal 
cancer. There was not a statistically significant difference found between rural provider's (M = 
60.63, SD = 19.90) and urban provider's (M = 68.00, SD = 19.14), t (47) = -1.32, p > .05 
estimated percentage of how many patients 2 50 are actually screened for colorectal cancer. 
Null hypothesis3 was rejected. There was a statistically significant difference found 
between rural and urban provider's estimated screening for colonoscopies. Urban providers 
estimated a higher percent of screening with colonoscopy (M = 76.04, SD = 20.12) compared to 
rural providers (M = 45.70, SD = 28.77), t (39) = - 4.18, p < .05. Urban providers estimated a 
statistically higher percentage of screening for colorectal cancer with colonoscopy than rural 
providers t (39) = - 4.18, p < .05. 
Since a difference was found between urban and rural providers screening with 
colonoscopy, the other screening methods were tested in a post-hoc fashion. In addition to 
differences in colonoscopy screening, rural providers (M = 49.52, SD = 33.15) estimated a 
statistically higher percentage of screening for colorectal cancer with FOBT than urban providers 
(M = 19.58, SD = 21.17), t (37) = 3.67, p <  .05 (Table 7). 
Table 7 
Differences Between Rural and Urban Providers Colorectal Cancer Screening Practices 
Practices Mean Standard Deviation Sarn~le Size 
Rural Urban Total Rural Urban Total Rural Urban Total 
Recommend 94.79 95.30 95.15 6.99 8.44 7.66 24 26 5 1 
Actually 60.63 68.00 64.40 19.85 19.15 19.45 24 25 5 0 
Screen 
Colonoscopy 45.70 76.04 61.17 28.77 20.12 28.56 23 24 48 
FOBT 49.52 19.58 35.40 33.15 21.17 32.00 23 24 48 
Note. The values represent provider's estimated mean percentages 
In summary, although there were no differences found between rural and urban providers' 
recommending and actual screening practices, there were rural and urban differences found 
within the screening methods. Rural providers had higher rates of screening their patients with 
colonoscopies and urban providers had higher rates of screening with FOBT. 
Hypothesis Four 
Hypothesis four stated that provider's attitudes and beliefs regarding colorectal cancer screening 
would predict engagement of certain screening methods. 
HO4: Provider's attitude regarding the effectiveness of a colorectal cancer 
screening procedure's ability to reduce mortality fi-om colorectal cancer will not 
predict engagement in that screening procedure. 
H4: Provider's attitudes regarding the effectiveness of a colorectal cancer 
screening procedure's ability to reduce mortality fi-om colorectal cancer will 
predict engagement in that screening procedure. 
Specifically, 
H4*: There will be a relationship between a provider's belief that 
screening for colorectal cancer with fecal occult blood testing 
reduces mortality from colorectal cancer with the provider's 
estimated percentage of screening patients by fecal occult blood 
testing. 
H4B: There will be a relationship between a provider's belief that 
screening for colorectal cancer with flexible sigmoidoscopy 
mortality from colorectal cancer with the provider's estimated 
percentage of screening patients by flexible sigmoidoscopy. 
H4c: There will be a relationship between a provider's belief that 
screening for colorectal cancer with colonoscopy reduces mortality 
from colorectal cancer with the provider's estimated percentage of 
screening patients by colonoscopy. 
The Pearson r moment coefficient test was used to analyze the above hypotheses. IVull 
hypothesis 4~ & 4~ were retained as there were no relationships found between provider's belief 
that screening with FOBT reduces mortality from colorectal cancer with the provider's estimated 
percentage of screening patients by FOBT; likewise for colonoscopy (Table 8). However, null 
hypothesis4B was rejected. There was a weak negative relationship (r = -.327, p < .05) found 
between provider's belief that flexible sigmoidoscopy reduces mortality from colorectal cancer 
and the percentage of screening with flexible sigmoidoscopy (Table 8). 
The negative relationship between the estimated percent of flexible sigmoidoscopy 
screening with the belief that screening with flexible sigmoidoscopy can reduce mortality from 
colorectal cancer from is difficult to explain. The providers being sampled belong to a healthcare 
system that discourages the practice of flexible sigmoidoscopies, even if the providers think this 
procedure can reduce mortality. Weaning away from flexible sigmoidoscopy has been done due 
to the fact that many colon cancers are being found in the right colon, an area that flexible 
sigmoidoscopy can not reach. Thus, a possible explanation for the negative relationship finding is 
administrative in nature. 
Table 8 
Correlations Between the Estimated Percent of Screening for Each Method with Beliefs 
of Each Screening Method's Ability to Reduce Mortality 
Flexible 
Sigmoidoscopy Colonoscopy 
FOBT Percent Percent Percent 
FOBT reduces 48 .003 - - - - 
mortality 
Flexible 
sigmoidoscopy 
reduces mortality 
Colonoscopy 
reduces mortality - - - - 
* p < .05 (2 -tailed) 
Hypothesis Five 
Hypothesis five stated there would be a relationship between providers who were familiar with 
screening guidelines and their general screening practices. 
HO5: There will be no relationship between providers who are familiar with the 
American Cancer Society screening guidelines and their general colorectal cancer 
screening practices. 
H5: There will be a relationship between level of familiarity with the American 
Cancer Society guidelines and general colorectal cancer screening practices. 
The Pearson r moment coefficient test was used to assess the possible relationship 
between level of familiarity with the American Cancer Society guidelines and the estimated 
percentage of patients screened for colorectal cancer. Results indicate null hypothesis4 failed to 
be rejected (r = .03, p > 0.5), suggesting that the degree to which a provider is familiar with the 
screening guidelines has no bearing on if they will screen age appropriate patients for colorectal 
cancer. 
Post-Hoc Analyses 
Since there were differences found between rural and urban screening methods, perceived 
patient preference by location was analyzed. Even though rural providers, as compared to urban 
providers, perceived that their patients preferred colonoscopy less (rural 54%; urban 81%), it was 
found that rural providers actually perceived their patients to prefer a colonoscopy (54%) over a 
FOBT (38%) procedure. This preference for colonoscopy over FOBT was found for urban 
providers as well (colonoscopy 8 1%; FOBT 12%). 
With further inspection, there was a relationship found between provider's level of 
agreement that their patients would comply with having a flexible sigmoidoscopy as the 
screening method with provider's colonoscopy estimation rates (r = .479, p > .01). This suggests 
that if providers think patients will comply with having an invasive procedure such as a flexible 
sigmoidoscopy, the provider would recommend a more thorough method of screening that is 
compliant with the healthcare system guidelines, a colonoscopy. Thus, making the estimation 
rate of screening with flexible sigmoidoscopy low even if the provider believes this type of 
screening method can reduce mortality. The negative correlation between the estimated percent 
of flexible sigmoidoscopy screening and with the belief that screening with flexible 
sigmoidoscopy can reduce mortality from colorectal cancer increased only with urban providers. 
This may suggest that urban providers who have colonoscopies more readily available and 
believe their patients would be more compliant with an invasive procedure would be more likely 
to screen their patients with a colonoscopy verses their rural counterparts. 
The lack of relationship found between providers' beliefs of which method can reduce 
mortality from colorectal cancer and which methods are actually being done led to post-hoc 
analyses as well. Specific variables of interest were location of provider and provider factors. 
Regarding location, rural providers use FOBT as their most frequent screening method (M = 
49.52) while urban providers use colonoscopy as their most frequent screening method (M = 
76.04). Interestingly, both rural and urban providers most definitely agreed that colonoscopy 
reduces mortality from colorectal cancer, rural (M = 4.71, SD = 0.46) and urban (M = 4.76, SD = 
0.44); while both rural and urban providers were less confident with the agreement that FOBT 
reduces mortality, rural (M = 3.75, SD = .74) and urban (M = 3.54, SD = 1.33). 
Regarding provider specific factors, providers may believe that a certain screening 
method may reduce mortality, however, the provider may also give the patient options as to 
which test to have and/or give the patient the ultimate decision. Different factors may influence 
which screening method a patient decides to have done such as invasiveness of procedure, 
insurance coverage, ability to get to a specialist office for a colonoscopy, and patient's attitude of 
seriousness of the testing. Since the patients were not surveyed however, analysis can only be 
inferred about characteristics of the provider and provider beliefs regarding their patients. 
FOBT and colonoscopy appear to be the methods used most often by providers in this study. 
Since screening with colonoscopy appears to be the "gold standard" for screening for colorectal 
cancer, there was interest in determining which factors were predictive of screening with the gold 
standard, and without (i.e. FOBT). To determine which factors predict provider's use of 
screening with FOBT, two models were entered into a linear regression. The reduced model 
consisted of main effects and the full model consisted of main effects and interaction effects 
(Table 9). 
Table 9 
Predictor Variables of Interest for FOBT 
Main Effects Interaction Effects 
Factor 1 : Provider's perception of patient's Factor 6: Location of providers multiplied by 
preference for FOBT. whether or not the patient requested testing. 
Factor 2: The use of a reminder system, either Factor 7: Location of providers multiplied by 
paper or computer. provider's perception of patient's preference 
for FOBT. 
Factor 3: Influence of availability of colorectal 
cancer screening procedures. Factor 8: Location of providers multiplied by 
whether or not availability of colorectal cancer 
Factor 4: Influence of patients requesting to be screening procedures influenced screening 
tested. pattern. 
Factor 5: Location of providers, rural or urban. Factor 9: Location of providers multiplied by 
whether or not providers use a reminder system 
The full model, containing both the main and interaction effects, did not have statistically 
significant predictive power in determining what accounts for the use of FOBT screening above 
and beyond the reduced model. The effect of the main predictor variables did not vary across 
rurallurban location. 
The reduced model with only main effects was found to be significant (F = 13.18 < .05, 
R~ = .56). Of the four main effect variables entered into the model two were significant: 
providers perceive their patients to prefer FOBT (P = .60, t = 5.50 < .05) and location of the 
providers (P = -.30, t = -2.77 < .05). The stronger of the two predictors, accounting for 36% of 
unique variance, suggests that the more the provider perceives their patient to prefer FOBT, the 
higher the rate of using FOBT as a screening method. Location of the provider did not show to be 
as of a strong predictor, but did predict about 9% of the variance uniquely, indicating that 
providers who practice in rural settings are more likely to use FOBT as a screening method. 
Together, these two variables accounted for 45% of the variance in predicting provider's use of 
screening with FOBT. 
The same logic was used in determining which factors predict provider's use of screening 
with colonoscopy. Two models were entered into a linear regression with the reduced model 
consisting of main effects and the full model consisting of main effects and interaction effects 
(Table 10). 
Table 10 
Predictor Variables of Interest for Colonoscopy 
Main Effects Interaction Effects 
Factor 1 : Provider's perception of patient's Factor 6: Location of providers multiplied by 
preference for colonoscopy. whether or not the patient requested testing. 
Factor 2: The use of a reminder system, either Factor 7: Location of providers multiplied by 
paper or computer. provider's perception of patient's preference 
for colonoscopy. 
Factor 3: Influence of availability of colorectal 
cancer screening procedures. Factor 8: Location of providers multiplied by 
whether or not availability of colorectal cancer 
Factor 4: Influence of patients requesting to be screening procedures influenced screening 
tested. pattern. 
Factor 5: Location of providers, rural or urban. 
Factor 9: Location of providers multiplied by 
whether or not providers use a reminder system 
The results for predicting colonoscopy screening were similar to the results for predicting 
FOBT screening. The full model, containing both the main and interaction effects, did not have 
predictive power in determining what accounts for the use of colonoscopy screening. However, 
the reduced model showed to be significant (F = 9.16, p< .05, R~ = .47). Of the four variables, 
two were significant: provider's perception of patient preference for a colonoscopy (P = .41, t = 
3.37 p< .05) and location of the providers (P = .42, t = 3.42 p< .05). The two predictors suggest 
that the more the provider perceives their patient to prefer colonoscopy, the higher the rate of 
using colonoscopy as a screening method. Also, providers who practice in an urban setting are 
more likely to use colonoscopy as a screening method. Together, these two variables accounted 
for 35% of the variance in predicting provider's use of screening with colonoscopy. This suggests 
that a provider's perception of a patient's screening preference and location of provider play a 
factor in choosing the type of colorectal cancer screening procedure. 
Summary of Findings 
Although the population size was small, the high response rate indicates that these 
findings are generalizable to this specific population. Significant results of the composition of the 
two groups were that little over half of the rural providers had medical degrees; the remaining 
50% were either physician assistants or nurse practitioners. Almost all of the rural providers 
practiced in family medicine. All urban providers had medical degree, and although most 
practiced in family medicine, a sizeable amount practiced in internal medicine as well. 
Differences were found between rural and urban providers in the type of screening 
performed. Specifically, rural providers estimated higher FOBT screening and lower colonoscopy 
screening compared to urban providers. In an attempt to identify which variables predict which 
type of procedure is performed, regression analyses were done. Results of these analyses suggest 
that the provider's perception of patient's screening preference as well as the provider's location 
predicts screening practices of the providers. This is highlighted by the fact that rural providers 
did have a much higher rate of perceived patient preference for an FOBT compared to urban 
providers. 
Yet, this latter finding is misleading if not further explored. Rural providers actually 
perceived their patients to prefer a colonoscopy (54%) to an FOBT (38%). However, their 
estimation rates of actual practices were much closer in range than would be expected based 
upon patient preference data (FOBT 50%; colonoscopy 46%). Interestingly, this was not found 
with urban providers. This group of providers had a much larger gap in procedures performed 
(FOBT 20%; colonoscopy 76%), as expected given the large difference in perceived patient 
procedure preference. 
One possible explanation for this greater discrepancy with rural providers is that rural 
providers have decreased access to colonoscopies. Although not a stastistically significant 
difference, there were more rural providers (21%) than urban providers (12%) who slightly or 
strongly agreed that the lack of availability made it difficult to use colonoscopy as a screening 
method. 
CHAPTER FIVE: DISCUSSION 
Summary 
Colorectal cancer is a preventable disease; yet, the number of people who are screened in 
compliance with the American Cancer Guidelines is still relatively low. National prevalence data 
show that 26% of the U.S. population reported to have had an FOBT in the last two years and 
53% reported to have ever had a colonoscopy or flexible sigmoidoscopy (National Center for 
Chronic Disease Prevention & Health Promotion, 2004). Colorectal cancer is a silent killer as it 
takes years for a polyp to become cancerous and the symptoms often go unnoticed until it is too 
late. Although only 1% of polyps become cancerous, there is no way to determine which polyp 
will become cancerous. Early detection and removal of polyps by routine screening reduces the 
chance of ever acquiring this disease by 75%. 
The goal of screening for colorectal cancer is to identify cancers and polyps in the colon 
and rectum. However, in order for organizations to recommend population screenings for a 
desired disease, experts must agree that the screening tests accurately detect the disease. 
Primarily, scientists look for tests that demonstrate significantly lower mortality from the targeted 
disease due to screening compared to a population who is not being screened (Champion, Raw1 
& Menon, 2002). The American Cancer Society has identified FOBT, flexible sigmoidoscopy, 
double contrast barium enema and colonoscopy as appropriate screening methods for colorectal 
cancer. 
Yet, FOBT is not a sensitive test and can miss early stages of cancers and polyps. Due to 
the test's low sensitivity, there is still a large percentage (67-85%) of people dying from 
colorectal cancer who have used FOBT as a method of screening. 
Flexible sigmoidoscopy allows for direct visualization of the distal bowel, along with the 
ability to obtain a biopsy specimen of suspicious lesions. However, lesions in the proximal 
bowel, or two-thirds of the bowel, are not detected. The percent of colorectal cancers in the 
proximal bowel that go undetected by flexible sigmoidoscopy have been reported to be as high 
40% (Mayo Clinic Staff, 2003). 
A colonoscopy is the most sensitive test as it allows visualization of the entire colon and 
rectum, along with the option of removing biopsies of any abnormalities found. However, it is 
the most evasive and expensive method and some insurance companies do not reimburse for it. 
Taylor and Anderson (2002) conducted a study of primary care physicians in Wisconsin 
and found large differences between the estimated percent of screening rates for the different 
methods. Specifically, a very small percent of physicians estimated that they screened their 
patients with colonoscopy, while a much larger percent estimated that their patients were 
screened with FOBT. 
Findings specific to the present study concur with past research in that there continue to 
be differences between screening methods. Overall, without separating the physicians by location 
of practice, there were differences found between methods. Specifically, a large percentage of 
physicians use colonoscopy (62%), and only 36% use FOBT. This is the opposite of past research 
where the majority of physicians report using FOBT more often. This finding is very promising 
for the healthcare system in this study as it suggests there is progress being made in screening 
behavior towards the gold standard. The percentage of providers screening in this specific 
healthcare system with colonoscopies is higher than the national average, which is less than 50%. 
A second interesting finding of the Taylor and Anderson (2002) study was that there was 
an inconsistency of physician belief and practice. Although almost all respondents either strongly 
or slightly agreed to the statement, "Every patient over 50 years of age should be screened for 
colorectal cancer," only one forth of the respondents estimated that they screened 75% or more of 
their patients who were 50 years or older. Interestingly, however, Taylor and Anderson (2002) 
did not examine how many physicians recommend patients 50 years or older to have a screening 
procedure. There may have been discrepancies between physician's belief and practice due to 
behaviors and attitudes of his or her patients, not necessarily of the physician. A physician may 
think every patient who is 50 and older should be screened, and recommend this to every patient 
who fits the criteria, but still have a low screening rate of patients who are actually screened due 
to factors related to the patient and location of practice. 
Another reason could be that the providers surveyed could only recommend their patients 
to have a colonoscopy because they can't perform the procedure, so naturally their estimation 
rates of actually screening would be low. Specifically, in order to perform the procedure, a 
provider needs a medical degree and, if the person is a family practice doctor, additional 
specialized educational training is required (Worthington, 2000). 
The discrepancies between physician belief and practices found in the Taylor and 
Anderson (2002) study provoked the inclusion of supplemental questions in this study to help 
determine if there were underlying factors operating to explain the discrepancy discussed above. 
Specifically, given the results from the earlier study, there was a need to distinguish between 
urban and rural providers. In addition, questions regarding rates of recommending screening 
procedures were also included. If differences in recommending occurred, it could help explain 
previously found differences in screening. 
Findings from the present study show that even though over half of all providers surveyed 
estimated that they screened for colorectal cancer with colonoscopies, the type of location, rural 
or urban, was related to significant differences in screening practices. The fact that rural 
providers estimated a much higher percent of screening with FOBT and the urban providers 
estimated a much higher percent of screening with colonoscopy demonstrates that healthcare 
discrepancies between locations still exist. 
According to the predictive models tested, a provider's perceived patient preference 
should have some impact on the estimated screening rate. While urban provider's estimation 
rates and perceived patient preference had a large gap between colonoscopies and FOBT, both 
favoring colonoscopies, rural providers actually perceived their patients to prefer a colonoscopy. 
Yet, rural providers still had a slightly more frequent estimation rate of using FOBT. This 
suggests that something else plays a role in determining the test that is used within the rural 
areas. 
The other added factor to this study was the question asking the providers to estimate the 
percent of patients they recommended having a colorectal cancer procedure. In hindsight, an 
estimation of recommendation to each procedure should have been asked, as well as if they are 
eligible to perform colonoscopies As mentioned before, it was found that rural providers actually 
perceived their patients to prefer a colonoscopy rather than FOBT, however, the screening rates 
do not reflect this. Since more than half of rural providers do not have a licensed medical degree, 
and only one who practices internal medicine, it would be interesting to know to how many 
patients rural providers recommend each procedure and which providers are able to perform the 
procedure It is logical that urban providers would report a higher estimate of colonoscopies 
because there were more licensed and eligible providers in the urban areas who can perform this 
procedure. Rural providers could have a high rate of recommending a colonoscopy, but a low rate 
of performing one because they can't perform the procedure, while the urban providers could 
have performed the colonoscopy of the patient who was referred by the rural provider. 
Limitations 
Four limitations exist in this study. The first is that the results cannot be generalized to 
providers outside of this healthcare system. The second is the small sample size of the study, 
however, it does reflect the true size of the population. The third limitation is the degree to 
which true percentages for the different screening methods had to be inferred and recalculated. 
These recalculated scores were the basis for comparisons between rural and urban providers' 
practices, as well as for the regressions in determining if there were factors that could predict 
either FOBT or colonoscopy screening. The last limitation is that this study does not uncover the 
causal reasons as to why there are discrepancies in the different methods of screening for 
colorectal cancer between rural and urban providers. On this, there can only be speculation and 
some relationship data until further research is done. 
Conclusions 
The fact that there were no differences between rural and urban provider's rates of 
recommending screening and the overall rate of having any screening method done suggests that 
no matter where the providers are practicing they all perceive screening to be important. 
However, the method of screening seems to be a function of provider location and possibly the 
provider's perception of patients' preference. The strength of this latter finding is questionable 
however, for although rural providers perceived their patients to prefer FOBT far more often than 
urban providers did, rural providers still perceived that their patients preferred a colonoscopy 
more than FOBT. A factor worth investigating would be asking the providers to report how many 
patients they recommend for each specific procedure. 
The differences between rural and urban providers' screening method suggests healthcare 
discrepancies exist for this specific population. Rural providers reported lower rates of screening 
their 50 years of age or older patients with colonoscopy, which is the "gold standard," yet the 
most expensive test. Rural providers reported higher rates of screening with FOBT, which is the 
least invasive, least expensive test. 
Research suggests that rural and urban healthcare discrepancies are due to a community's 
economic and educational level as well as insurance coverage and accessibility. Specifically, 
FOBT can be done in the comfort of one's own home and doesn't require an evasive 
appointment with a specialist, which most likely would be in a larger, more urban neighboring 
city. All insurances cover this method of screening and if a person does not have insurance, it is 
the least expensive screening test for colorectal cancer. In contrast, colonoscopies are evasive, 
expensive and done by a specialist. Regarding this last issue, the findings from this study suggest 
that most rural providers, specific to this Wisconsin sample, compared to urban providers, do not 
have the training necessary to provide a colonoscopy. 
Any of the above factors, alone or in combination, can be determining factors of who gets 
which screening method. However, there is insufficient data from this research to draw any firm 
conclusions about why there are differences between rural and urban providers. 
Implications 
These results can help bring insight to colorectal cancer screening practices in this 
specific healthcare system. From this study, it is apparent that rural providers in this healthcare 
system are not screening with colonoscopies at the ideal rate. This information could be used as 
evidence for the need to request governmental funding assistance to recruit and hire licensed 
internal medicine providers in underserved areas, specifically rural areas, or to provide training to 
the current rural-based family practice physicians. In addition, this type of information would be 
helpful in planning educational campaigns for patients and by knowing which population to 
target, and for creating educational training sessions for rural providers on how to educate their 
patients on the importance of colorectal cancer screening and how to actively engage them in the 
decision process. 
Recommendations 
There is evidence to suggest that there is something different between rural and urban 
practices re colorectal screening in this specific Wisconsin healthcare system. However, further 
research would be needed to determine if the differences were due to the patient demographics, 
such as income or educational level, or if it was due to characteristics of the providers or 
healthcare system practices. 
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Appendix A: Colorectal Cancer Screening Survey 
Please answer the following questions and return to Corporate 
Communications by Tuesday, March 16,2004. 
1. For patients at average risk, please check: 
a. Your most preferred method of screening for colorectal cancer: (Check only one) 
Fecal occult blood testing (FOBT) every year 
Flexible sigmoidoscopy every 5 years 
P FOBT every year combined with flexible sigmoidoscopy every 5 years 
P Colonoscopy every 10 years 
P Double contrast barium enema every 10 years 
P Other, please specify 
b. What you believe to be the majority of your patients' most preferred method of screening 
for colorectal cancer: (Check only one) 
P Fecal occult blood testing (FOBT) every year 
P Flexible sigmoidoscopy every 5 years 
P FOBT every year combined with flexible sigmoidoscopy every 5 years 
P Colonoscopy every 10 years 
P Double contrast barium enema every 10 years 
P Other, please specify 
2. Which method of screening for colorectal cancer would you choose for yourself if you were 
an average risk patient over 50 years of age: (Check only one) 
P Fecal occult blood testing (FOBT) every year 
P Flexible sigmoidoscopy every 5 years 
P FOBT every year combined with flexible sigmoidoscopy every 5 years 
P Colonoscopy every 10 years 
P Double contrast barium enema every 10 years 
Other, please specify 
3. For patients over 50 years of age, estimate what percentage.. . 
a. you recommend for a colorectal screening procedure YO 
b. are actually screened for colorectal cancer: YO 
c. are screened for colorectal cancer with: 
Fecal occult blood testing YO 
Flexible sigmoidoscopy YO 
Colonoscopy YO 
4. Estimate how many patients over 50 years of age you see each year in your clinical practice: 
Do you use a system to remind you when a patient is due for colorectal cancer screening? (Check 
only one) 
0 No 
0 Yes, paper system 
Yes, computer system 
5. Which of the following would make you more likely to screen for colorectal cancer: 
(Check all that apply): 
Reminder system 
Easy availability of screening tests 
Pamphlets for patients 
6. Other things that would help you? 
7. Has your screening pattern (type of test or frequency) for colorectal cancer changed in the 
past 4 years? 
No 0 Yes 
8. If yes, how has it changed? 
9. If yes, why has it changed? 
10. Which of the following have influenced your screening practices? (Check all that apply) 
Received ACS Screening Guidelines 
Read the Wisconsin Medical Journal screening article 
Read other medical journal articles 
Involved in CME courses/conferences 
0 Availability of screening procedures 
0 My patients have requested testing 
0 Other (please list) 
11. Please check your level of agreement or disagreement with the following statements: 
Strongly Slightly Neutral Slightly Strongly N/A 
Disagree Disagree Agree Agree 
I regularly screen my patients over 50 years of age 
for colorectal cancer. 
The guidelines for colorectal cancer screening are 
clear. 
I am familiar with the American Cancer Societv 
guidelines for colorectal cancer screening. 
A patient with a family history of colorectal 
cancer is at increased risk for developing 
- - 
colorectal cancer. 
Every patient over 50 years of age should be 
screened for colorectal cancer. 
If I were to recommend a colonoscopy as the 
screening test for colorectal cancer, my patients 
- . - A  
would comply. 
If I were to recommend fecal occult blood testing 
as the screening test for colorectal cancer, my 
patients would comply. 
If I were to recommend flexible sigmoidoscopy as 
the screening test for colorectal cancer, my 
~atients would com~lv.  
The cost of colonoscopy makes me hesitant to 
recommend colonoscopy screening for colorectal 
cancer. 
The risk of perforation from colonoscopy makes 
me hesitant to recommend colonoscopy screening 
for colorectal cancer. 
The lack of availability of colonoscopy makes it 
difficult to use colonoscopy as a screening tool 
for colorectal cancer. 
The lack of proof that screening with colonoscopy 
reduces mortality from colorectal cancer makes 
me hesitant to use colonoscopy as a screening 
tool. 
Screening for colorectal cancer with fecal occult 
blood testing reduces mortalitv from colorectal 
u 
cancer. 
Screening for colorectal cancer with flexible 
sigmoidoscopy reduces mortality from colorectal 
cancer. 
Screening for colorectal cancer by combining 
fecal occult blood testing with flexible 
sigmoidoscopy reduces mortality from colorectal 
cancer. 
Screening for colorectal cancer with colonoscopy 
reduces mortality from colorectal cancer. 
12. Do you currently perform flexible sigmoidoscopy? No LI Yes 
13. Do you currently perform colonoscopy? No LI Yes 
Demographics 
Although you are answering demographic questions, your responses will not be used to identify 
you in any report or thesis. 
14. Your gender: LI Male I3 Female 
15. Please check your age range: Under 30 
30-39 
LI 40-49 
LI 50-59 
LI 60-69 
70+  
17. Check what applies to you: LI M.D. P.A. LI N.P. 
18. Please check your department? LI Family Practice LI Internal Medicine 
19. What year did you receive your clinical degree? 
20. Please check the location of your primary office: 
LI Barron LI Bloomer LI Cameron LI Chetek LI Chippewa Falls 
Colfax LI Eau Claire-MCC LI Eau Claire-MCLC Mondovi 
LI Osseo LI Prairie Farm 
Thank you for your participation! 
Luther Midelfort 
Mayo Health System 
Appendix B: Categorization of Locations 
Categorization of Locations 
Rural n Urban n 
Barron 
Bloomer 
Cameron 
Chetek 
Colfax 
Mondovi 
Osseo 
Total 
Chippewa Fall 
Eau Claire 
7 
5 
2 
1 
2 
2 
5 
24 
5 
2 1 
26 
